🇺🇸 FDA
Patent

US 11219633

Nucleobase analogue derivatives and their applications

granted A61KA61K31/7068A61K47/542

Quick answer

US patent 11219633 (Nucleobase analogue derivatives and their applications) held by The Board of Regents of the University of Texas System expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7068, A61K47/542